Latest profit margin for Chiasma: -29.68% — see history and peer comparisons.
Get informed when a big investor buys or sells
+ FollowAs of Mar 2021
Trailing 12 months ending Mar 2021
Chiasma (CHMA) currently reports a profit margin of -29.68% as of March 2021. That is below the Healthcare sector average of 15.58%. Use the charts on this page to explore Chiasma's profit margin history and peer comparisons.
Chiasma's profit margin of -29.68% is lower than the Healthcare sector average of 15.58%. That is roughly 19147.4% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
There is no universal 'good' profit margin, but Chiasma's current -29.68% should be judged against Healthcare norms (sector average: 15.58%) and against CHMA's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.
Start with the current profit margin of -29.68%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 15.58%. From there, open related valuation or income-statement pages for Chiasma, and consider following CHMA for alerts when major investors trade the stock.
Chiasma is classified in the Healthcare sector. On profit margin, it currently shows -29.68% versus a sector average near 15.58%. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing CHMA with unrelated industries.